About: BMS-906024

Property	Value
dbo:abstract	BMS-906024 is a drug with a benzodiazepine structure, developed by Bristol-Myers Squibb and disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and is being studied in clinical trials. (en) Il BMS-906024 è uno farmaco con struttura benzodiazepinica sviluppato dalla casa farmaceutica Bristol-Myers Squibb e presentato nella primavera 2013 durante l'American Chemical Society a New Orleans per il trattamento del cancro al seno, ai polmoni, al colon e alla leucemia. Il farmaco funziona come un inibitore di pan-Notch. La struttura fa parte di un insieme brevettato nel 2012, ed è in fase di studio. (it)
dbo:casNumber	1401066-79-2
dbo:fdaUniiCode	DRL23N424R
dbo:pubchem	66550890
dbo:thumbnail	wiki-commons:Special:FilePath/BMS-906024.svg?width=300
dbo:wikiPageID	39087520 (xsd:integer)
dbo:wikiPageLength	4724 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1069845619 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Benzodiazepine dbr:Notch_signaling_pathway dbr:Bristol-Myers_Squibb dbc:Experimental_cancer_treatments dbr:American_Chemical_Society dbc:Benzodiazepines
dbp:c	26 (xsd:integer)
dbp:casNumber	1401066 (xsd:integer)
dbp:chemspiderid	28536138 (xsd:integer)
dbp:f	6 (xsd:integer)
dbp:h	26 (xsd:integer)
dbp:iupacName	-N-[-1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-2,3-bissuccinamide (en)
dbp:n	4 (xsd:integer)
dbp:o	3 (xsd:integer)
dbp:pubchem	66550890 (xsd:integer)
dbp:pubchemsubstance	152143555 (xsd:integer)
dbp:smiles	CN1c2ccccc2Cc3ccccc3 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	AYOUDDAETNMCBW-GSHUGGBRSA-N (en)
dbp:unii	DRL23N424R (en)
dbp:wikiPageUsesTemplate	dbt:Antineoplastic-drug-stub dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Fdacite dbt:Benzodiazepines
dcterms:subject	dbc:Experimental_cancer_treatments dbc:Benzodiazepines
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatCancerTreatments yago:Abstraction100002137 yago:Act100030358 yago:Activity100407535 yago:Care100654885 yago:Event100029378 yago:PsychologicalFeature100023100 yago:Work100575741 yago:YagoPermanentlyLocatedEntity dbo:Drug yago:Treatment100658082
rdfs:comment	BMS-906024 is a drug with a benzodiazepine structure, developed by Bristol-Myers Squibb and disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and is being studied in clinical trials. (en) Il BMS-906024 è uno farmaco con struttura benzodiazepinica sviluppato dalla casa farmaceutica Bristol-Myers Squibb e presentato nella primavera 2013 durante l'American Chemical Society a New Orleans per il trattamento del cancro al seno, ai polmoni, al colon e alla leucemia. Il farmaco funziona come un inibitore di pan-Notch. La struttura fa parte di un insieme brevettato nel 2012, ed è in fase di studio. (it)
rdfs:label	BMS-906024 (en) BMS-906024 (it)
owl:sameAs	freebase:BMS-906024 yago-res:BMS-906024 wikidata:BMS-906024 dbpedia-it:BMS-906024 dbpedia-sh:BMS-906024 dbpedia-sr:BMS-906024 https://global.dbpedia.org/id/YKB3
prov:wasDerivedFrom	wikipedia-en:BMS-906024?oldid=1069845619&ns=0
foaf:depiction	wiki-commons:Special:FilePath/BMS-906024.svg
foaf:isPrimaryTopicOf	wikipedia-en:BMS-906024
is dbo:wikiPageRedirects of	dbr:C26H26F6N4O3
is dbo:wikiPageWikiLink of	dbr:Bristol_Myers_Squibb dbr:C26H26F6N4O3
is foaf:primaryTopic of	wikipedia-en:BMS-906024